1. Home
  2. APAM vs WVE Comparison

APAM vs WVE Comparison

Compare APAM & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artisan Partners Asset Management Inc.

APAM

Artisan Partners Asset Management Inc.

HOLD

Current Price

$37.66

Market Cap

2.7B

Sector

Finance

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$6.59

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APAM
WVE
Founded
1994
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.4B
IPO Year
2011
2015

Fundamental Metrics

Financial Performance
Metric
APAM
WVE
Price
$37.66
$6.59
Analyst Decision
Hold
Strong Buy
Analyst Count
5
16
Target Price
$43.00
$29.81
AVG Volume (30 Days)
634.3K
3.9M
Earning Date
04-28-2026
04-28-2026
Dividend Yield
10.81%
N/A
EPS Growth
10.66
N/A
EPS
0.76
N/A
Revenue
$1,196,688,000.00
$3,704,000.00
Revenue This Year
$5.96
N/A
Revenue Next Year
$5.05
$85.67
P/E Ratio
$48.79
N/A
Revenue Growth
7.63
149.43
52 Week Low
$34.99
$5.02
52 Week High
$48.46
$21.73

Technical Indicators

Market Signals
Indicator
APAM
WVE
Relative Strength Index (RSI) 52.81 41.52
Support Level $35.40 $6.51
Resistance Level $38.49 $7.65
Average True Range (ATR) 0.74 0.34
MACD 0.08 0.06
Stochastic Oscillator 75.90 41.95

Price Performance

Historical Comparison
APAM
WVE

About APAM Artisan Partners Asset Management Inc.

Artisan Partners Asset Management Inc is a investment management firm providing a range of investment strategies to a diverse group of clients around the world. Each of the company's strategies is managed by one of its several investment teams. Investment management services are offered to institutions through separate accounts and mutual funds. Artisan's investment offerings include several long-only, equity investment strategies across a multitude of market capitalization segments and investing styles in both the United States and international markets. The company operates as one segment in the investment management business. The company generates maximum portion of its revenues from clients domiciled in countries outside the United States.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: